Core Viewpoint - Huge Dental Limited (Shandong Hujie Dental Medical Group Co., Ltd.) is making its third attempt to go public on the Hong Kong Stock Exchange after facing multiple challenges in its previous IPO attempts in China [1][2]. Group 1: Company Background and IPO Journey - Established in November 2006, Huge Dental is the largest manufacturer of dental impression materials in China and one of the largest manufacturers of clinical dental materials [5]. - The company was listed on the New Third Board in 2015 but delisted in 2017, subsequently attempting to IPO on the A-share market multiple times from 2017 to 2023, all of which ended unsuccessfully due to various regulatory concerns [5]. - Key issues highlighted during the A-share attempts included significant shareholding irregularities and financial control problems, which were major factors in the failed IPOs [5]. Group 2: Financial Performance and Challenges - The company's revenue growth has stagnated, with projected revenues of 3.58 billion, 3.99 billion, and 4.00 billion yuan for 2023, 2024, and 2025 respectively, showing a decline in growth rate from 27.86% to 11.45% and then to just 0.25% [10]. - Net profit has also been on a downward trend, with figures of 0.88 billion, 0.77 billion, and 0.48 billion yuan for the same years, indicating a significant drop of 37.7% in 2025 [10]. - The company's high operating expenses are concerning, with sales, administrative, and R&D costs accounting for 42.4% of revenue in the first half of 2025, severely impacting profitability [11]. Group 3: Market Position and Competitive Landscape - Huge Dental's business is heavily concentrated in traditional dental materials, with 97.8% of revenue coming from clinical and technician products, while digital products contribute only 0.2% [11]. - The company faces intense competition in high-growth areas like invisible orthodontics, where its market share remains below 2%, despite price reductions [11]. - The average price of its synthetic resin teeth has remained stable at 0.9 yuan per piece, indicating a price-sensitive market [11]. Group 4: Future Growth Strategies - The company aims to expand production capacity and pursue international markets as part of its growth strategy, with plans to enhance production lines in Rizhao, Shandong, and invest in digital technology [12]. - However, the overseas revenue share has decreased from 46.95% in 2021 to 23.85% in 2024, raising questions about the effectiveness of its international expansion efforts [12].
多次冲A无果,这家行业老大转战港股,实控人IPO前大额套现......
IPO日报·2026-03-03 00:33